From: Prognostic biomarkers related to breast cancer recurrence identified based on Logit model analysis
 | Category | Term | Count | p value |
---|---|---|---|---|
Upregulation | BP | GO:0006955~immune response | 67 | 1.270E−27 |
GO:0006952~defense response | 45 | 1.130E−13 | ||
GO:0019882~antigen processing and presentation | 14 | 9.100E−09 | ||
CC | GO:0044459~plasma membrane part | 75 | 9.160E−08 | |
GO:0005887~integral to plasma membrane | 45 | 6.820E−06 | ||
GO:0005886~plasma membrane | 103 | 7.390E−06 | ||
MF | GO:0019955~cytokine binding | 10 | 2.910E−04 | |
GO:0008236~serine-type peptidase activity | 10 | 8.588E−03 | ||
GO:0017171~serine hydrolase activity | 10 | 9.209E−03 | ||
KEGG | hsa04514:Cell adhesion molecules (CAMs) | 15 | 9.070E−06 | |
hsa04612:Antigen processing and presentation | 12 | 1.040E−05 | ||
hsa04062:Chemokine signaling pathway | 17 | 3.180E−05 | ||
Downregulation | BP | GO:0045137~development of primary sexual characteristics | 5 | 8.024E−03 |
GO:0009968~negative regulation of signal transduction | 6 | 1.340E−02 | ||
GO:0007548~sex differentiation | 5 | 1.409E−02 | ||
CC | GO:0044456~synapse part | 7 | 1.228E−02 | |
GO:0045202~synapse | 8 | 2.139E−02 | ||
GO:0005761~mitochondrial ribosome | 3 | 3.516E−02 | ||
MF | GO:0048306~calcium-dependent protein binding | 3 | 1.372E−02 | |
GO:0005509~calcium ion binding | 14 | 1.696E−02 | ||
GO:0008083~growth factor activity | 5 | 2.078E−02 | ||
KEGG | hsa04514:Cell adhesion molecules (CAMs) | 3 | 2.108E−02 | |
hsa04150:mTOR signaling pathway | 2 | 2.884E−02 | ||
hsa03018:RNA degradation | 2 | 3.115E−02 |